A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR)
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
- Status
- RECRUITING
- Phase
- NA
Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
- Status
- AVAILABLE
- Phase
- N/A
Combination Immunotherapy Targeting Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of GC101 TIL in Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Sun Protection and Tanning Awareness in Rural Schools
- Status
- COMPLETED
- Phase
- NA
Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults
- Status
- RECRUITING
- Phase
- N/A
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
- Status
- RECRUITING
- Phase
- N/A
Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy
- Status
- RECRUITING
- Phase
- NA
Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)
- Status
- RECRUITING
- Phase
- PHASE2
Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management
- Status
- RECRUITING
- Phase
- N/A
LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
- Status
- RECRUITING
- Phase
- N/A
Study to Examine Lesions of the Skin Using Confocal Laser Microscopy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®
- Status
- TERMINATED
- Phase
- PHASE3